Thilsiam
Product hming: Retatrutide .
A tlem berah chuan vial/box 10, 10 a awm ang.
Pawisa pek: T/T, Bitcoin, Western Union, Credit Card, Bank transfer, PayPal,Alibaba, Alipay, WeChat,wise
Delivery: 1000000 box/week
Delivery: Pawisa pek zawh veleh thawn chhuah nghal .
A rilru a buai em em a, a rilru a hah em em bawk a, a rilru a buai em em bawk a, a rilru a hah em em bawk a. 10mg/vial, 15mg/vial, 20mg/vial, 30mg/vial
Retatrutide hi GLP-1 (glucagon-peptide-1 ang chi, GIP (glucose{6}}a innghat insulin-stimulating peptide) leh Glucagon receptor novel triple agonist a ni. Multi-target hypoglycemic drug a nih angin thisen glucose control nasa takin a tichak a, taksa rihna a tichak a, a ruala enteroinsulin-stimulating receptor pathum activate-in cardiovascular metabolism-ah hlawkna tam tak a thlen thei bawk.
A hnathawh dan tur .
Receptor pathum activate-in combined effect a nei a:
1.GLP-1 receptor: Insulin secretion a tichak a, glucagon a tikhawlo a, gastric emptying a tikhawtlai a, satiety a tipung bawk.
2.GIP receptor: Insulin sensitivity a ti tha a, energy metabolism a tidanglam bawk.
3.Glucagon receptor: thau tihchhiatna a tichak a, energy hmanralna a tipung bawk.
Product a thatna te .
1.Triple Excitation Mechanism: A rualin GLP-1, GIP leh glucagon receptor te chu a tichak a, chu chuan metabolism chu a tichak a ni.
2.Highly effective hypoglycemic effect: Type 2 diabetes mellitus (T2DM) vei te thisen glucose level (HBA1C) nasa takin a tihniam a.
3.Significant Weight Loss: Clinical data atanga a lan dan chuan weight loss effect hi single/double receptor agonists (semaglutide leh tielpotide ang chi) te aiin a tha zawk tih a lang.
4.Metabolism comprehensive improvement: A hlawkna awm thei te chu thisen lipids tihhniam te, fatty liver tihchangtlun te leh cardiovascular protection pek te a ni.
hot tags .: GLP taksa rihna tihtlem Peptide Retatrutide 30mg, China GLP taksa rihna tihtlem 30mg siamtu, supplier, factory